Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2022-01-10 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-01-10 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing changes to the company's board of directors, specifically the appointment and resignation of board members. It contains no financial data, no report or presentation, and no mention of voting results or other regulatory filings. The content focuses solely on management changes at the board level. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (8008 characters) supports that it is a full announcement rather than a brief notice or report publication announcement.
2022-01-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing Avicanna's first commercial export of Cannabigerol (CBG) into the European Union, specifically the Czech Republic. It discusses the company's business activities, product details, and market expansion. There are no financial statements, regulatory filings, or detailed financial performance data included. The document is a corporate announcement about a commercial milestone rather than a financial report, regulatory filing, or management discussion. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The content is best classified as a general corporate announcement about business development, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2021-12-24 English
News release - English.pdf
Regulatory Filings
2021-12-22 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new product line (re+PLAY branded CBD topicals) by Avicanna in partnership with Harrington Wellness. It contains detailed product descriptions, company background, and forward-looking statements. There is no indication of financial data, regulatory filings, voting results, or management changes. It is a corporate announcement about a product launch rather than a financial report, regulatory filing, or meeting material. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous corporate news, which corresponds to Regulatory Filings (RNS).
2021-12-20 English
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing Avicanna's participation in the Lytham Partners Winter 2021 Investor Conference, including details about a webcasted Fireside Chat and virtual investor meetings. It provides company background and forward-looking statements but does not contain any financial results, detailed financial data, or regulatory filings. It is an investor event announcement rather than a financial report, earnings release, or regulatory filing. Therefore, it best fits the category of an Investor Presentation (IP) or a general investor event announcement. Since it is not a detailed presentation document but an announcement of participation in an investor conference, the closest fitting category is Investor Presentation (IP).
2021-12-10 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.